KATHERINE FREEMAN: Open Payments
NPI 1346655834 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 30 payments from 10 companies in 2025. Trend: 2023 $507 · 2024 $971 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $165 |
| Novo Nordisk Inc | 5 | $116 |
| Radius Health, Inc. | 4 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| Lilly USA, LLC | 3 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| ABBVIE INC. | 2 | $35 |
| Mallinckrodt Hospital Products Inc. | 1 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
Products named: Bimzelx, Tymlos, Ozempic, Kerendia, Wegovy, ACTHAR, JARDIANCE, GEMTESA.
Industry payments across SC — which companies pay providers there.
